Biomarker discovery for disease status and symptom severity in children with autism.
Oztan O, Jackson LP, Libove RA, Sumiyoshi RD, Phillips JM, Garner JP, Hardan AY, Parker KJ.
Oztan O, et al.
Psychoneuroendocrinology. 2018 Mar;89:39-45. doi: 10.1016/j.psyneuen.2017.12.022. Epub 2017 Dec 28.
Psychoneuroendocrinology. 2018.
PMID: 29309996
Free PMC article.
Further analysis revealed that a composite measure of OXTR and AVPR1A gene expression was the key driver of group classification, and that children with ASD had lower neuropeptide receptor mRNA levels compared to controls. ...Findings from this research highlight the value …
Further analysis revealed that a composite measure of OXTR and AVPR1A gene expression was the key driver of group classification, and …